Steve Profit – General Manager, Novo Nordisk Taiwan
Steve Profit, general manager of Novo Nordisk Taiwan, shares a newcomers’ perspective as a recent transplant to the market from the company’s global office in Denmark. Profit goes on to…
Address: 7F-1, No.216, Sec.2, Tun Hua South Road, Taipei 106, Taiwan
,Taiwan
Tel: (02)2377-2566
Web: http://www.novonordisk.com.tw/documents/home_page/document/index.asp
Novo Nordisk is a global healthcare company with 87 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Novo Nordisk Taiwan received several awards from patients associations, mainly for supporting those organisations’ activities such as diabetes patients’ camps or patients’ clubs via booth or speech programs. Novo Nordisk Taiwan received an award from Taiwan Diabetes Association for special dedication and contribution during World Diabetes Day 2007.
Pharmaceuticals
Steve Profit, general manager of Novo Nordisk Taiwan, shares a newcomers’ perspective as a recent transplant to the market from the company’s global office in Denmark. Profit goes on to…
Novo Nordisk is one of the few pharmaceutical multinationals focused in one key therapeutic area. Perhaps you could start by telling our readers about how diabetes has evolved in Taiwan…
Tung-Mao Su, chairman of TPMA, highlights the association’s historic significance in cultivating Taiwan’s pharmaceutical industry, its members’ most pressing concerns, and outlines the developments of the company which he leads…
Ting-Kuo Lee, Academician of Academia Sinica and chairman of the Taiwan Nanotechnology Industry Development Association, explains the history and mission of the association to promote Taiwan’s nano sector and gives…
HB Chen, president of TaiwanBio Therapeutics, introduces the innovative stem cell company and elaborates on their patented cell expansion technique for the production of mesenchymal stem cells (MSC). Chen then…
Katie Lai, associate director of Medpace Taiwan, introduces the company’s history in Taiwan and highlights the CRO’s unique service offering as a partner of choice to the biotech sector. Lai…
Taiwan boasts a booming life sciences sector and is striving to innovate through collaboration. Here we present five of the key executives and stakeholders who are aiming to drive the…
Albert Lu (founder) and Helen Chiu (co-founder) of Tripod Nano Technology (TPNT), introduce the concept of the original innovative manufacturer (OIM) of metal nanoparticle colloidal solutions and highlight the company’s…
Dr Wen-je Ko, mayor of Taipei City, discusses his plans for creating a key biocluster in the city and goes on to share his views on the government’s role to…
Dr Chien-Huang Lin, tenth president of Taipei Medical University, shares his personal mission upon taking the role, elaborates on the research strengths of TMU, and goes on to discuss the…
Dr Fu-Tong Liu, vice president of Academia Sinica, introduces the institution and its research mission of promoting basic research and enhancing translation. Dr Liu goes on to describe Academia Sinica’s…
Betty Li, managing director of PPC, a well-positioned leader in the APAC CRO landscape, speaks about the strategic significance of the group’s Taiwan affiliate and goes on to share her…
Lily Wu, CEO of PapiVax, discusses the biotechs initiative pipeline for the treatment of HPV related diseases and cancers and goes on to elaborate the company’s development and future partnership…
Luke Chen, co-founder and CEO of PuriBlood, speaks about the innovative spin-off technology developed at the R&D Center for Membrane Technology at Chung Yuan Christian University. The company’s leukocyte reduction…
See our Cookie Privacy Policy Here
